Patents by Inventor William Wilson Turner

William Wilson Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic peptide antifungal agents and process for preparation thereof
    Patent number: 7790744
    Abstract: Provided are compounds of the formula (1): wherein R? is hydrogen, methyl or NH2C(O)CH2—; R? and R?? are independently methyl or hydrogen; R adn Ry are independently hydroxy or hydrogen; R1 is hydroxy, hydrogen, or hydroxysulfonyloxy; R7 is hydroxy, hydrogen, hydroxysulfonyloxy or phosphonooxy; R2 is a novel acyl side chain. Also provided are novel formulations, methods of inhibiting fungal and parasitic activity, and a process for preparing dideoxy (R?H) forms of the compounds.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: September 7, 2010
    Assignee: Eli Lilly and Company
    Inventors: Frederick J. Burkhardt, Manuel Debono, Jeffrey S. Nissen, William Wilson Turner, Jr.
  • Muscarinic agonists
    Patent number: 7378447
    Abstract: The present invention relates to compounds of Formula (I): which are agonists of the M-1 muscarinic receptor
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: May 27, 2008
    Assignee: Eli Lilly and Company
    Inventors: Jennifer Rebecca Allen, Stephen Andrew Hitchcock, William Wilson Turner, Bin Liu
  • Muscarinic agonists
    Patent number: 7326731
    Abstract: The present invention relates to compounds of Formula I: Formula I which are agonists of the M-1 muscarinic receptor.
    Type: Grant
    Filed: September 9, 2002
    Date of Patent: February 5, 2008
    Assignee: Eli Lilly and Company
    Inventors: Jennifer Rebecca Allen, Stephen Andrew Hitchcock, James Andrew Jamison, Bin Liu, William Wilson Turner, Jr.
  • Indane derivates as muscarinic receptor agonists
    Patent number: 7265246
    Abstract: The present invention relates to compounds of Formula I: I which are agonists of the M-1 muscarinic receptor
    Type: Grant
    Filed: June 23, 2004
    Date of Patent: September 4, 2007
    Assignee: Eli Lilly and Company
    Inventors: Jennifer Rebecca Allen, Stephen Andrew Hitchcock, Bin Liu, William Wilson Turner
  • Ring modified cyclic peptide analogs
    Patent number: 6939946
    Abstract: A method for modifying the cyclic peptide ring system of Echinocandin-type compounds to produce new analogs having antifungal activity is provided. The inventive process comprises opening the cyclic peptide ring, cleaving the terminal ornithine unit, inserting at least one new amino acid or other synthetic unit and closing the ring to produce a new cyclic peptide ring structure. The process allows one to incorporate features such as water-solubility into the cyclic peptide ring nucleus, sites for further modification, increase or decrease the number of amino acid or peptide units within the ring nucleus, and increase or decrease the total number of members within the ring. The invention further provides novel Echinocandin type compounds and their use as antifungal or anti-parasitic agents.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: September 6, 2005
    Assignee: Eli Lilly and Company
    Inventors: Peter Stanley Borromeo, Jeffrey Daniel Cohen, George Stuart Gregory, Stacy Kay Henle, Stephen Andrew Hitchcock, Louis Nickolaus Jungheim, Daniel Ray Mayhugh, Timothy Alan Shepherd, William Wilson Turner, Jr.
  • Muscarinic agonists
    Publication number: 20040242584
    Abstract: The present invention relates to compounds of Formula 1: Formula 1 which are agonists of the M-1 muscarinic receptor.
    Type: Application
    Filed: March 3, 2004
    Publication date: December 2, 2004
    Inventors: Jennifer Rebecca Allen, Stephen Andrew Hitchcock, James Andrew Jamison, Bin Liu, William Wilson Turner
  • Ring modified cyclic peptide analogs
    Patent number: 6653281
    Abstract: A method for modifying the cyclic peptide ring system of Echinocandin-type compounds to produce new analogs having antifungal activity is provided. The inventive process comprises opening the cyclic peptide ring, cleaving the terminal omithine unit, inserting at least one new amino acid or other synthetic unit and closing the ring to produce a new cyclic peptide ring structure. The process allows one to incorporate features such as water-solubility into the cyclic peptide ring nucleus, sites for further modification, increase or decrease the number of amino acid or peptide units within the ring nucleus, and increase or decrease the total number of members within the ring. The invention further provides novel Echinocandin type compounds and their use as antifungal or anti-parasitic agents.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: November 25, 2003
    Assignee: Eli Lilly and Company
    Inventors: Peter Stanley Borromeo, Jeffrey Daniel Cohen, George Stuart Gregory, Stacy Kay Henle, Stephen Andrew Hitchcock, Louis Nickolaus Jungheim, Daniel Ray Mayhugh, Timothy Alan Shepherd, William Wilson Turner, Jr.
  • Cyclic peptide antifungal agents
    Patent number: 5693611
    Abstract: Provided are pharmaceutical formulations, and methods of inhibiting fungal and parasitic activity using a compound of formula I ##STR1## wherein: R', R", R'", R.sup.x1, R.sup.x2, R.sup.y1, R.sup.y2, R.sup.y3, R.sup.y4, and R.sup.0 are as defined herein below;R.sup.2 is a novel acyl side chain. Also provided are novel formulations and methods of inhibiting fungal and parasitic activity.
    Type: Grant
    Filed: January 17, 1997
    Date of Patent: December 2, 1997
    Assignee: Eli Lilly and Company
    Inventors: Stacy Kay Henle, William Wilson Turner